Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Belgium / NCT07552519
Recruiting Observational

Patient Reported Outcome Measurements Registration in Spinal Pathologies and Neuromodulation

NCT07552519 · tracked via the Priya Life Science Belgium tracker
Sponsor
Jessa Hospital
Phase
Observational
Started
2026-04
Last updated
2026-04-27

Condition(s) studied

Spinal PathologiesPainCervical PainLumbar Pain SyndromeNeurostimulationDisc Degenerative Disease

Study summary

Longitudinal prospective observational data collection with questionnaires and categorical diagnostic and therapeutic registration and follow-up in spinal pathologies and neuromodulation

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Clinical diagnosis of spinal disease 2. Clinical indication to perform treatment of this disease 3. willing and capable to provide informed consent 4. Age ≥18 y Exclusion Criteria: not able to provide consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
JEssa Ziekenhuis Hasselt Limburg Recruiting

More Jessa Hospital trials in Belgium

Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity Recruiting
Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction Recruiting
Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy Recruiting
Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors Recruiting
Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy Recruiting

Other trials for the same condition

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain Recruiting
Somatosensory Phenotyping of ADPKD Recruiting
Cognitive Trance, Hypnosis and Meditation in Oncology Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07552519 on ClinicalTrials.gov ↗ ← All trials in Belgium